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Intr
Patients with haematological malignancies admitted to
ICU have high mortality. Reticence of intensive care
providers to admit and treat these patients is well
described in literature.
Objectives
To evaluate differences between survivors and non-
survivors and provide possible independent risk factors
for ICU mortality.
Methods
Single centre observational retrospective study in a
14-bed Intensive Care Unit of a University Hospital. All
haematological patients admitted between January-2009
and December-2014 were enrolled. Data acquired
included: demographics characteristics, haematological
diagnosis, reason of ICU admission, severity-of-illness
scores (APACHE and SOFA) and intensive care therapy
(mechanical ventilation (VM), extrarenal therapy
depuration (ETD) and vasopressor support (VS)).
Results
We included 38 patients in the study,15(39,47%) were
survivors and 23(60,52%) were non-survivors. Median
age of 50,47 ± 13,98 vs 59,78 ± 14,73 (p > 0,05) and
predominance of males in both groups (60% vs 73,9%,
p > 0,05), respectively. In both groups non-Hodgkin
lymphoma was the most frequent haematological malig-
nancy, 53% and 30,4 %, survivors and non-survivors
respectively and acute respiratory failure was the most
frequent reason for ICU admission(66% and 39,1%,
respectively). Intergroup comparisons revealed statisti-
cally significant differences in APACHE (19,73 ± 8,05 vs
26,48 ± 8,74, p < 0,05) and SOFA (9 ± 3,4 vs 11,83 ±
3,23, p < 0.05). During the first 24h of ICU admission,
60% of the survivors patients had 2 or more organ fail-
ures, and 73,9% in non-survivors group. During evolu-
tion in ICU, survivors patients required VM and VS in
80% and 66,7%, respectively. None of them needed
EDT. Non-survivors required VM and VS in 91% and
95,7% respectively, and 17,4% needed EDT. There were
no statistically significant differences in ICU support thera-
pies between survivors and non-survivors. No independent
risk factors for mortality were found by logistic regression
analysis.
Conclusions
Mortality in patients with haematological malignancies
remains high. There were significant differences in severity-
of-illness scores during the first twenty-four hours of ICU
admission between survivors and non-survivors. No signifi-
cant differences in intensive care therapy were found
between groups during ICU hospitalization.
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